1.
Oni ET, Agatston AS, Blaha MJ, et al. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? Atherosclerosis. 2013;230(2):258-267. doi:10.1016/j.atherosclerosis.2013.07.052
2.
Pastori D, Loffredo L, Perri L, et al. Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors. Am J Cardiol. 2015;115(10):1402-1406. doi:10.1016/j.amjcard.2015.02.032
3.
Cattazzo F, Lombardi R, Mantovani A, et al. Subclinical and clinical atherosclerosis in non-alcoholic fatty liver disease is associated with the presence of hypertension. Nutr Metab Cardiovasc Dis. 2022;32(12):2839-2847. doi:10.1016/j.numecd.2022.08.005
4.
Chen Y, Xu M, Wang T, et al. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease. Atherosclerosis. 2015;241(1):145-150. doi:10.1016/j.atherosclerosis.2015. 05.002
5.
Velarde-Ruiz Velasco JA, García-Jiménez ES, García-Zermeño KR, et al. Extrahepatic complications of non-alcoholic disease fatty liver R. Rev Gastroenterol Mex (Engl Ed). 2019;84(4):472-481. doi:10.1016/j.rgmx. 2019.05.004
6.
Li N, Zhang GW, Zhang JR, et al. Non-alcoholic fatty liver disease is associated with progression of arterial stiffness. Nutr Metab Cardiovasc Dis. 2015;25(2):218-223. doi:10.1016/j.numecd.2014.10.002
7.
Oni E, Budoff MJ, Zeb I, et al. Nonalcoholic fatty liver disease is associated with arterial distensibility and carotid intima-media thickness: (from the multi-ethnic study of atherosclerosis). Am J Cardiol. 2019;124(4):534-538. doi:10.1016/j.amjcard.2019.05.028
8.
Zhu W, Deng CJ, Xuan LP, et al. Peripheral artery disease and risk of fibrosis deterioration in nonalcoholic fatty liver disease: a prospective investigation. Biomed Environ Sci. 2020;33(4):217-226. doi:10.3967/bes 2020.031
9.
Taharboucht S, Guermaz R, Brouri M, Chibane A. Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: a case-control study in Algerian population. J Med Vasc. 2021;46(3):129-138. doi:10.1016/j.jdmv.2021.03.008
10.
Liu S, Wang J, Wu S, et al. The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: a prospective analysis. Metabolism. 2021;120:154779. doi:10.1016/j.metabol.2021.154779
11.
Cicero AFG, Gitto S, Fogacci F, et al. Fatty liver index is associated to pulse wave velocity in healthy subjects: data from the Brisighella heart study. Eur J Intern Med. 2018;53:29-33. doi:10.1016/j.ejim.2018.03.010